Nexavar

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 04/29/13 - 05:24 pm
thyroid cancer
Caprelsa
AstraZeneca
Cometriq
Exelixis
Nexavar
Bayer
ONYX Pharmaceuticals
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
breast cancer
aromatase inhibitors
AstraZeneca
Novartis
Femara
Arimidex
SERMs
Nolvadex
Roche
Herceptin
GSK
Tykerb
Xeloda
Perjeta
Kadcyla
Immunogen
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
ONYX Pharmaceuticals
India board rules against Bayer in cancer drug patent case
Reuters
Mon, 03/4/13 - 10:43 am
Bayer
India
patents
Nexavar
Bayer's Nexavar meets goal in thyroid cancer trial
Reuters
Thu, 01/3/13 - 11:34 am
Bayer
Nexavar
refractory differential thyroid cancer
Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients
Bloomberg
Sat, 09/29/12 - 11:57 am
Nexavar
Bayer
lung cancer
4SC in Talks With 3 Potential Partners for Cancer Drug
Bloomberg
Thu, 09/13/12 - 09:50 am
4SC
liver cancer
Resminostat
Nexavar
Bayer
FDA Approval and a Trial Failure: Which Is More Important?
Motley Fool
Mon, 07/23/12 - 10:50 pm
FDA
ONYX Pharmaceuticals
Kyprolis
Nexavar
Bayer says Nexavar-Tarceva trial unsuccessful
Reuters
Mon, 07/23/12 - 08:55 am
Nexavar
Tarceva
Bayer
liver cancer
ONYX Pharmaceuticals
Nexavar: Are 3 Failed Phase 3 Trials Enough?
Motley Fool
Thu, 05/24/12 - 10:13 am
Bayer
Onyx
Nexavar
lung cancer
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Yahoo/AP
Tue, 05/22/12 - 09:42 am
Bayer
Onyx
Nexavar
lung cancer
Bayer appeals India patent office ruling
MarketWatch
Sat, 05/5/12 - 04:58 pm
Bayer
patents
Nexavar
generics
Onyx Pharma CFO plugs cancer pipeline amid rumored sales process
Fierce Biotech
Fri, 01/13/12 - 09:29 am
ONYX Pharmaceuticals
Pfizer
Takeda
M&A
cancer
Nexavar
Bristol-Myers Says Liver Cancer Drug Didn’t Meet Goals in Trial
Bloomberg
Fri, 12/23/11 - 08:44 am
liver cancer
Bristol-Myers Squibb
brivanib
Nexavar
ONYX Pharmaceuticals
Bayer
Onyx Pharmaceuticals Said to Weigh Sale as It Explores Strategic Options
Bloomberg
Tue, 11/29/11 - 08:24 am
ONYX Pharmaceuticals
Nexavar
M&A
Carfilzomib
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Pfizer Goes for a One-Two Blockbuster Knockout
Motley Fool
Fri, 05/20/11 - 09:42 am
kidney cancer
Pfizer
Sutent
Axitinib
Bayer
ONYX Pharmaceuticals
Nexavar
Onyx, Bayer say Nexavar fails in lung cancer study
Yahoo/AP
Mon, 06/14/10 - 02:37 pm
Bayer
ONYX Pharmaceuticals
Nexavar
lung cancer
clinical trials
Bayer’s Nexavar Fails to Win Backing of U.K. Agency
Bloomberg
Wed, 05/26/10 - 08:49 am
Bayer
UK
Nexavar
liver cancer
How Concerned Should Onyx Investors Be?
Seeking Alpha
Sun, 05/2/10 - 10:52 am
Nexavar
ONYX Pharmaceuticals

Pages